D. Fraser

发表

Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens

E. Diamandis, I. Prassas, A. Soosaipillai, 2022, Clinical chemistry and laboratory medicine.

Endothelial Glycocalyx Degradation in Critical Illness and Injury

E. Patterson, G. Cepinskas, D. Fraser, 2022, Frontiers in Medicine.

Pretreatment of Human Cerebrovascular Endothelial Cells with CO‐releasing Molecule‐3 Interferes with JNK/AP‐1 Signaling and Suppresses LPS‐induced Proadhesive Phenotype

E. Patterson, G. Cepinskas, D. Fraser, 2015, Microcirculation.

ArticleCritically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-

J. Zeidler, D. O'Gorman, Claudio M. Martin, 2021 .

Neutrophil serine proteases in vitro: How much and why?

E. Patterson, G. Cepinskas, D. Fraser, 2022, Journal of leukocyte biology.

CXCL1/CXCL8 (GRO (cid:1) /IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro /IL-8) in human ketoacidosis plasma

P. Couraud, I. Romero, B. Weksler, 2014 .

Diabetic Ketoacidosis Elicits Systemic Inflammation Associated with Cerebrovascular Endothelial Cell Dysfunction

T. Omatsu, E. Patterson, G. Cepinskas, 2013, Microcirculation.

Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism

Shannon Seney, M. Knauer, Mark Daley, 2022, Molecular Medicine.

In ammation and Endothelial Injury Pro ling in COVID-19 Pediatric Multi-system In ammatory Syndrome

D. Fraser, 2020 .

Novel plasma protein biomarkers from critically ill sepsis patients

Claudio M. Martin, Mark Daley, M. Slessarev, 2022, Clinical Proteomics.

Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

A. House, S. Lemoine, C. McIntyre, 2022, Scientific Reports.

Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients

Shannon Seney, Mark Daley, M. Slessarev, 2022, Heliyon.

Proteinase 3 contributes to endothelial dysfunction in an experimental model of sepsis

Claudio M. Martin, M. Slessarev, E. Patterson, 2021, Experimental biology and medicine.

Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses

J. Zeidler, D. O'Gorman, Claudio M. Martin, 2021, Pathophysiology : the official journal of the International Society for Pathophysiology.

System-wide hematopoietic and immune signaling aberrations in COVID-19 revealed by deep proteome and phosphoproteome analysis

T. Kaneko, M. Ye, C. Martin, 2021, medRxiv.

T helper type 2‐polarized invariant natural killer T cells reduce disease severity in acute intra‐abdominal sepsis

S. Haeryfar, J. McCormick, S. Porcelli, 2014, Clinical and experimental immunology.

COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management

Claudio M. Martin, M. Slessarev, G. Cepinskas, 2022, Journal of cellular and molecular medicine.

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning

M. Knauer, Mark Daley, Maitray A. Patel, 2023, Molecular Medicine.

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality

D. Dwivedi, P. Liaw, K. Liaw, 2021, Critical care explorations.

Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay

E. Diamandis, I. Prassas, Claudio M. Martin, 2021, Clinical chemistry and laboratory medicine.

Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern

S. Li, T. Kaneko, P. Stogios, 2021, JCI insight.

Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants

P. Stogios, T. Skarina, E. Evdokimova, 2021, medRxiv.

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

M. Dimopoulos, E. Terpos, A. Falanga, 2022, Hemato.

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function

S. Drăghici, M. Knauer, G. Cepinskas, 2023, Journal of Translational Medicine.

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function

S. Drăghici, M. Knauer, G. Cepinskas, 2023, Journal of Translational Medicine.

Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens

J. Cruz-Aguado, M. Slessarev, Michael R. Miller, 2022, medRxiv.

Tachykinins and the potential causal factors for post-COVID-19 condition

E. Diamandis, A. Baird, I. Prassas, 2023, The Lancet. Microbe.

The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

Sanam Alilou, D. Fraser, A. Behnoush, 2023, BMC Infectious Diseases.

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study

D. Dwivedi, P. Liaw, Claudio M. Martin, 2021, Journal of Thrombosis and Haemostasis.

A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning

Mark Daley, Maitray A. Patel, G. Cepinskas, 2024, Clinical proteomics.

Pediatric sepsis inflammatory blood biomarkers that correlate with clinical variables and severity of illness scores

Mark Daley, Maitray A. Patel, G. Cepinskas, 2024, Journal of inflammation.

A Distinct Metabolite Signature in Military Personnel Exposed to Repetitive Low-Level Blasts

O. Vartanian, R. Jetly, C. Tenn, 2022, Frontiers in Neurology.

A novel multiplex biomarker panel for profiling human acute and chronic kidney disease

Mark Daley, Maitray A. Patel, S. Badrnya, 2023, Scientific reports.